Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors
Sponsor: M.D. Anderson Cancer Center
Terminated
\<75 % participation
Other terminated trials from M.D. Anderson Cancer Center
Other Lung Cancer trials with similar outcome
This NA trial investigates Lung Cancer and is currently terminated or withdrawn. M.D. Anderson Cancer Center leads this study, which shows 10 recorded versions since 2022 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Sep 2025 — Dec 2025 [monthly]
Active Not Recruiting NA
-
Mar 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Nov 2024 — Mar 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jun 2024 [monthly]
Recruiting NA
-
Jun 2023 — Dec 2023 [monthly]
Recruiting NA
-
Dec 2022 — Jun 2023 [monthly]
Recruiting NA
First recorded
Nov 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .